search
Back to results

Determine the Effect of Targeted High-definition Transcranial Direct Current Stimulation (tDCS) on Reducing Post-stroke Upper Limb Motor Impairments

Primary Purpose

Stroke

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Transcranial direct current stimulation (high- definition)
Sponsored by
Carle Foundation Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Stroke focused on measuring Stroke, Non-invasive Brain Stimulation, Movement Impairment

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Paresis confined to one side, with substantial motor impairment of the paretic upper limb
  • Capacity to provide informed consent

Exclusion Criteria:

  • Muscle tone abnormalities and motor or sensory impairment in the non-paretic limb
  • Severe wasting or contracture or significant sensory deficits in the paretic upper limb
  • Severe cognitive or affective dysfunction that prevents normal communication and understanding of consent or instruction
  • Severe concurrent medical problems (e.g. cardiorespiratory impairment)
  • Using a pacemaker
  • Metal implants in the head
  • Known adverse reactions to TMS and tDCS
  • Pregnant

Sites / Locations

  • Carle Foundation HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Active Comparator

Active Comparator

Sham Comparator

Arm Label

Anodal stimulation

Cathodal stimulation

Bilateral Stimulation

Sham stimulation

Arm Description

Anodal stimulation targets the primary motor cortex (arm area) in the lesioned hemisphere, sham on the contralesional hemisphere.

Cathodal stimulation targets the dorsal premotor cortex (arm area) in the contralesional hemisphere, sham on the lesioned hemisphere.

Anodal stimulation targets the primary motor cortex (arm area) in the lesioned hemisphere and cathodal stimulation targets the dorsal premotor cortex (arm area) in the contralesional hemisphere at the same time.

Sham stimulation to both hemisphere of the brain

Outcomes

Primary Outcome Measures

Change in Transcranial Magnetic Stimulation-Evoke Motor-evoked Potential 1: Ispilesional stimulation in the brain and contralateral response in the muscle
This is a neurophysiological measure that determines the use of the ipsilesional corticospinal tract.
Change in Transcranial Magnetic Stimulation-Evoke Motor-evoked Potential 2: Contralesional stimulation in the brain and ipsilateral response in the muscle
This is a neurophysiological measure that determines the use of the contralesional cortico-reticulospinal tract.

Secondary Outcome Measures

Change in a subset of Fugl-Meyer Upper Extremity assessment which is mainly related to the muscle synergies
This clinical measure is mainly related to the upper limb muscle synergies
Change in Fugl-Meyer Upper Extremity assessment
This reflects the overall motor impairment level.

Full Information

First Posted
July 26, 2022
Last Updated
August 28, 2023
Sponsor
Carle Foundation Hospital
Collaborators
American Heart Association
search

1. Study Identification

Unique Protocol Identification Number
NCT05479006
Brief Title
Determine the Effect of Targeted High-definition Transcranial Direct Current Stimulation (tDCS) on Reducing Post-stroke Upper Limb Motor Impairments
Official Title
Determine the Effect of Targeted High-definition tDCS on Reducing Post-stroke Upper Limb Motor Impairments
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 30, 2022 (Actual)
Primary Completion Date
June 30, 2025 (Anticipated)
Study Completion Date
June 30, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Carle Foundation Hospital
Collaborators
American Heart Association

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Significant motor impairments occur in 80% of individuals after moderate to severe stroke and impact the body side to the lesioned hemisphere. Typical motor impairments involve loss of dexterity with highly prevalent upper limb flexion synergy. Advances in treating flexion synergy impairments have been hampered by a lack of precision rehabilitation. Previous studies suggest and support the role of cortico-reticulospinal tract (CRST) hyperexcitability in post-stroke flexion synergy. CRST hyperexcitability is often caused by damage to the corticospinal tract (CST). We hypothesize that: 1) inhibiting the contralesional dorsal premotor cortex (cPMd) will directly reduce the CRST hyperexcitability and thus, reduce the expression of the flexion synergy; 2) facilitating the ipsilesional primary motor cortex (iM1) will improve the excitability of the damaged CST, therefore reducing the CRST hyperexcitability and the flexion synergy. we propose to use a novel targeted high-definition tDCS (THD-tDCS) to specifically modulate the targeted cortical regions for testing his hypothesis, via the following aims: Aim 1. Evaluate the effect of cathodal THD-tDCS over the cPMd on reducing the CRST hyperexcitability and the expression of flexion synergy. Aim 2. Evaluate the effect of anodal THD-tDCS over the iM1 on improving the excitability of the CST, and determine whether this, thus, also reduces the CRST hyperexcitability and the flexion synergy. Aim 3. Evaluate the confluence effect of bilateral THD-tDCS, i.e., simultaneous cathodal stimulation over the cPMd and anodal over the iM1.
Detailed Description
This sham-controlled cross-over study design will include four visits: 1) anodal stimulation targeting the ipsilesional hemisphere, 2) cathodal one at the contralesional hemisphere, 3) bilateral stimulation with anodal on the ipsilesional hemisphere and cathodal on the contralesional hemisphere and 4) a sham stimulation visit. The sequence of the stimulations will be randomized and double-blinded (assessor and participants). After each intervention, there will be at least 2 weeks wash-out period before participants receive the next intervention and assessments. Each visit will last up to 3 hours including the preparation time and breaks. We will use neuro-navigation high-definition tDCS (NNG HD-tDCS) to target specific brain regions in a more precise way than before. A subject-specific head model will be built to evaluate the effect of lesion size and location on the electrical field of tDCS. The MR images (if available, otherwise CT images) will be used to build this subject-specific head model. The stimulation electrode montage and inter-electrode distance will be carefully examined by computer simulation to determine the optimal setup and dosage for NNG HD-tDCS. The patient time commitment in this study is approximately 10 weeks where subjects have 4 x 1-day intervention and measurements, with 2 weeks washout the period in between. The total number of potential enrolled subjects in this pilot study is 30.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
Stroke, Non-invasive Brain Stimulation, Movement Impairment

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
This sham-controlled cross-over study design will include four visits: 1) anodal stimulation targeting the ipsilesional hemisphere, 2) cathodal one at the contralesional hemisphere, 3) bilateral stimulation with anodal on the ipsilesional hemisphere and cathodal on the contralesional hemisphere and 4) a sham stimulation visit. After each intervention, there will be at least 2 weeks wash-out period before participants receive the next intervention and assessments.
Masking
ParticipantOutcomes Assessor
Masking Description
The sequence of the stimulations will be randomized (generated in RedCap) and double-blinded (assessor and participants).
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Anodal stimulation
Arm Type
Active Comparator
Arm Description
Anodal stimulation targets the primary motor cortex (arm area) in the lesioned hemisphere, sham on the contralesional hemisphere.
Arm Title
Cathodal stimulation
Arm Type
Active Comparator
Arm Description
Cathodal stimulation targets the dorsal premotor cortex (arm area) in the contralesional hemisphere, sham on the lesioned hemisphere.
Arm Title
Bilateral Stimulation
Arm Type
Active Comparator
Arm Description
Anodal stimulation targets the primary motor cortex (arm area) in the lesioned hemisphere and cathodal stimulation targets the dorsal premotor cortex (arm area) in the contralesional hemisphere at the same time.
Arm Title
Sham stimulation
Arm Type
Sham Comparator
Arm Description
Sham stimulation to both hemisphere of the brain
Intervention Type
Device
Intervention Name(s)
Transcranial direct current stimulation (high- definition)
Intervention Description
20 minutes, 2 mA stimulation.
Primary Outcome Measure Information:
Title
Change in Transcranial Magnetic Stimulation-Evoke Motor-evoked Potential 1: Ispilesional stimulation in the brain and contralateral response in the muscle
Description
This is a neurophysiological measure that determines the use of the ipsilesional corticospinal tract.
Time Frame
Baseline (initial visit), before (within 30 min range) and immediately after (within 30 min range) the intervention
Title
Change in Transcranial Magnetic Stimulation-Evoke Motor-evoked Potential 2: Contralesional stimulation in the brain and ipsilateral response in the muscle
Description
This is a neurophysiological measure that determines the use of the contralesional cortico-reticulospinal tract.
Time Frame
Baseline (initial visit), before (within 30 minutes range) and immediately after (within 30 minutes range) the intervention
Secondary Outcome Measure Information:
Title
Change in a subset of Fugl-Meyer Upper Extremity assessment which is mainly related to the muscle synergies
Description
This clinical measure is mainly related to the upper limb muscle synergies
Time Frame
Baseline (initial visit), before (within 30 minutes range) and immediately after (within 30 minutes range) the intervention
Title
Change in Fugl-Meyer Upper Extremity assessment
Description
This reflects the overall motor impairment level.
Time Frame
Baseline (initial visit), before (within 30 minutes range) and immediately after (within 30 minutes range) the intervention
Other Pre-specified Outcome Measures:
Title
Modified Ashworth Scale
Description
This indicates the expression of muscle tone or spasticity
Time Frame
Baseline (initial visit), before (within 30 minutes range) and immediately after (within 30 minutes range) the intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Paresis confined to one side, with substantial motor impairment of the paretic upper limb Capacity to provide informed consent Exclusion Criteria: Muscle tone abnormalities and motor or sensory impairment in the non-paretic limb Severe wasting or contracture or significant sensory deficits in the paretic upper limb Severe cognitive or affective dysfunction that prevents normal communication and understanding of consent or instruction Severe concurrent medical problems (e.g. cardiorespiratory impairment) Using a pacemaker Metal implants in the head Known adverse reactions to TMS and tDCS Pregnant
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yuan Yang, PhD
Phone
217-244-5870
Email
yuan.yang@carle.com
First Name & Middle Initial & Last Name or Official Title & Degree
Sanjiv Jain, MD
Phone
217-383-3800
Email
sanjiv.jain@carle.com
Facility Information:
Facility Name
Carle Foundation Hospital
City
Urbana
State/Province
Illinois
ZIP/Postal Code
61801
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Carly Skadden, MPH
Phone
217-326-0102
Ext
1
Email
carly.skadden@carle.com
First Name & Middle Initial & Last Name & Degree
Sanjiv Jain, MD
Phone
217-383-3800
Email
sanjiv.jain@carle.com
First Name & Middle Initial & Last Name & Degree
Sanjiv Jain, MD
First Name & Middle Initial & Last Name & Degree
Yuan Yang, PhD, MS

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
We are committed to enhancing the value of research and furthering the advancement of public knowledge. We recognize that the public dissemination of our scientific results can facilitate the creation of collaborative efforts with domestic and international collaborators. Furthermore, we recognize that the proposed project may result in novel ideas for new methods, technologies, and data that could benefit the entire research community. Therefore, final research data will be shared openly and timely in accordance with the most recent NIH guidelines (http://grants.nih.gov/grants/policy/data_sharing/) while being mindful that the confidentiality and privacy of participants in research must be protected at all times.
Citations:
PubMed Identifier
28751255
Citation
McPherson JG, Stienen AH, Drogos JM, Dewald JP. Modification of Spastic Stretch Reflexes at the Elbow by Flexion Synergy Expression in Individuals With Chronic Hemiparetic Stroke. Arch Phys Med Rehabil. 2018 Mar;99(3):491-500. doi: 10.1016/j.apmr.2017.06.019. Epub 2017 Jul 24.
Results Reference
background
PubMed Identifier
36362680
Citation
Williamson JN, Sikora WA, James SA, Parmar NJ, Lepak LV, Cheema CF, Refai HH, Wu DH, Sidorov EV, Dewald JPA, Yang Y. Cortical Reorganization of Early Somatosensory Processing in Hemiparetic Stroke. J Clin Med. 2022 Oct 31;11(21):6449. doi: 10.3390/jcm11216449.
Results Reference
background

Learn more about this trial

Determine the Effect of Targeted High-definition Transcranial Direct Current Stimulation (tDCS) on Reducing Post-stroke Upper Limb Motor Impairments

We'll reach out to this number within 24 hrs